Longer treatment with puberty-delaying medication in transgender youth leads to lower bone mineral density

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

source https://medicalxpress.com/news/2022-06-longer-treatment-puberty-delaying-medication-transgender.html